Seeking AlphaWed, 27 May 2026 11:22:57 GMTDamora Therapeutics: Well-Funded Moonshot For CALR MutationsDMRA-3.96%
Zacks Investment ResearchMon, 20 Apr 2026 17:00:39 GMTWhat Makes Galecto, Inc. (DMRA) a Strong Momentum Stock: Buy Now?DMRA-3.96%
Zacks Investment ResearchFri, 10 Apr 2026 14:56:20 GMTHow Much Upside is Left in DAMORA THERAPEU (DMRA)? Wall Street Analysts Think 73.1%DMRA-3.96%